TuHURA Biosciences
HURA
8 hedge funds and large institutions have $338K invested in TuHURA Biosciences in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
100% more funds holding
Funds holding: 4 → 8 (+4)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
48% less capital invested
Capital invested by funds: $650K → $338K (-$312K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$169K |
| 2 |
Barclays
London,
United Kingdom
|
+$55K |
| 3 |
VF
Virtu Financial
New York
|
+$41K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$29.1K |
| 5 |
RE
RBC Europe
London,
United Kingdom
|
+$18.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$104K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $153K | +$169K | +157 | +29% |
|
|
2
Barclays
London,
United Kingdom
| $62K | +$55K | +51 | New |
|
|
VF
3
Virtu Financial
New York
| $46K | +$41K | +38 | New |
|
|
FIA
4
FNY Investment Advisers
New York
| $32K | +$29.1K | +27 | New |
|
|
RE
5
RBC Europe
London,
United Kingdom
| $20.7K | +$18.3K | +17 | New |
|
6
Renaissance Technologies
New York
| $12K | +$10.8K | +10 | New |
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $9K | +$8.63K | +8 | New |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| $3K | – | – | – |
|
|
CH
9
CVI Holdings
Wilmington,
Delaware
| – | -$104K | -108 | Closed |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$18K | -19 | Closed |
|
HURA Hedge Fund Activity: Q4 2019 in Review
8 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2019, worth a combined $338K — down 48% from $650K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HURA positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $169K. The largest seller was CVI Holdings, exiting entirely with an estimated $104K sold.
- 8 institutional investors held TuHURA Biosciences (HURA) as of Q4 2019, up from 4 in Q3 2019.
- Funds reported $338K of TuHURA Biosciences stock for Q4 2019, down 48% quarter-over-quarter.
- 6 funds opened new TuHURA Biosciences positions in Q4 2019 and 2 closed out, a net change of +4 holders.
- The largest TuHURA Biosciences buyer in Q4 2019 was Sabby Management, an estimated $169K added.
- The largest TuHURA Biosciences seller in Q4 2019 was CVI Holdings, an estimated $104K sold.
Based on aggregated 13F filings for Q4 2019.